Skip to main content
Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.9702
-0.0498 (-4.88%)
May 14, 2025, 10:46 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
Cancer Therapeutics
1.89M
Log In
Log In
Cancer Therapeutics Growth
-90.55%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022
Period Ending
 Dec '24 Dec '23 Dec '22
United States
1.89M
Log In
Log In
United States Growth
-90.55%
Log In
Log In